Related Experiment Video

Updated: Oct 15, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.2K

NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity

Kelley Ingram1,2, Shiela C Samson1,2, Rediet Zewdu2,3

  • 1Department of Oncological Sciences, University of Utah, Salt Lake City, UT, 84112, USA.

Oncogene
|October 24, 2021
PubMed

Insights

Lung adenocarcinoma (LUAD) progression is linked to the RAS-RAF-MEK-ERK pathway. The transcription factor NKX2-1 suppresses this pathway by inducing DUSP6, inhibiting tumor growth.

Area of Science:

  • Molecular biology
  • Oncology
  • Gene regulation

Background:

  • The RAS→RAF→MEK→ERK pathway is frequently hyperactivated in human lung adenocarcinoma (LUAD).
  • Feedback mechanisms limit ERK activity, but how sustained ERK activation drives LUAD progression remains unclear.

Purpose of the Study:

  • To investigate the role of the lung lineage transcription factor NKX2-1 in regulating ERK activity in LUAD.
  • To elucidate the mechanism by which NKX2-1 influences tumor progression and metastasis.

Main Methods:

  • Analysis of human LUAD tissue samples and cell lines.
  • Experiments using xenografts and genetic mouse models.
  • Investigated the interaction between NKX2-1, DUSP6, and the ERK pathway.

Main Results:

  • NKX2-1 suppresses ERK activity by inducing the expression of the ERK phosphatase DUSP6.
  • Silencing of NKX2-1 in late-stage LUAD leads to DUSP6 downregulation and promotes tumor growth and metastasis.
  • Re-introduction of NKX2-1 in silenced cells restores DUSP6 expression and inhibits tumor progression.

Conclusions:

  • NKX2-1 silencing and subsequent DUSP6 downregulation is a key mechanism enabling ERK hyperactivation in early LUAD.
  • DUSP6 is essential for NKX2-1-mediated inhibition of LUAD progression.
  • DUSP6 expression is sufficient to suppress RAS-driven LUAD, highlighting its therapeutic potential.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.1K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K